USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Heuron Co., Ltd.

USPTO PatentsView assignee record - 11 granted patents across 7 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

The verdict

According to USPTO PatentsView, Heuron ranks #24,465 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 7 technology areas.

#24,465
of 50,000 US assignees by volume
Top 59%
by Innovation Score (32.4/100)
13.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R24465 · Foreign Corporation #24,465 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 11 grants
  • MID-PACK #24,465/50,000
  • PHOTO-FINISH Havah Therapeutics Pty
  • CPC-NARROW A61B · 7 areas
  • INNOV-THIN 32.4/100
  • CLAIMS-RICH 13.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Havah Therapeutics Pty Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Heuron

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Heuron's Innovation Score is 32.4/100 (top 59% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Heuron's grants concentrate

Heuron Co., Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). Peak complete grant year is 2021 (5 grants) versus a trough of 1 in 2022. By volume, Heuron sits between Havah Therapeutics Pty Ltd. and Higgins Research & Development, Llc.

Heuron's three-year grant acceleration

Heuron Co., Ltd. shows 5 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Heuron's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Heuron holds 11 patents at rank #24,482, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Heuron

By rank, the assignees closest to #24,482 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Heuron's primary technology class.

Heuron's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 Top 59% higher than 41% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 20212022202320242025 1
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Heuron Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 5 45.5%
2022 1 9.1%
2023 2 18.2%
2024 2 18.2%
2025partial year 1 9.1%

Where it ranks

Overall rank by patents

#24,465

of 50,000 tracked assignees

Innovation Score

32.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.